Elmer 2017 US Patent
From Bioblast
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
Elmer E, Hansson MJ, Ehinger JK, Piel S, Moss S (2017) Succinate prodrugs for use in the treatment of lactic acidosis or drug-induced side-effects due to complex I-related impairment of mitochondrial oxidative phosphorylation. US Patent US20170100359 A1. |
Β» Open Access
Elmer E, Hansson MJ, Ehinger JK, Piel S, Moss S (2017) US Patent
Abstract: The present invention relates to a succinate prodrug for use in the treatment or prevention of lactic acidosis.
β’ Bioblast editor: Kandolf G β’ O2k-Network Lab: SE Lund Elmer E
Labels: MiParea: Respiration, Pharmacology;toxicology
Organism: Human
Tissue;cell: Heart, Blood cells, Fibroblast, Macrophage-derived, Platelet
Preparation: Intact cells
Coupling state: LEAK, ROUTINE, OXPHOS, ET
Pathway: S, ROX
HRR: Oxygraph-2k
Labels, PBMCs